150 related articles for article (PubMed ID: 3233491)
21. Evidence from confocal fluorescence microscopy for a dense, reciprocal innervation between AVP-, somatostatin-, VIP/PHI-, GRP-, and VIP/PHI/GRP-immunoreactive neurons in the rat suprachiasmatic nucleus.
Romijn HJ; Sluiter AA; Pool CW; Wortel J; Buijs RM
Eur J Neurosci; 1997 Dec; 9(12):2613-23. PubMed ID: 9517467
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin neurons form a distinct peptidergic neuronal group in the rat suprachiasmatic nucleus: a double labeling in situ hybridization study.
Tanaka M; Okamura H; Matsuda T; Shigeyoshi Y; Hisa Y; Chihara K; Ibata Y
Neurosci Lett; 1996 Sep; 215(2):119-22. PubMed ID: 8888010
[TBL] [Abstract][Full Text] [Related]
23. The control of circadian rhythms and the levels of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus are altered in spontaneously hypertensive rats.
Peters RV; Zoeller RT; Hennessey AC; Stopa EG; Anderson G; Albers HE
Brain Res; 1994 Mar; 639(2):217-27. PubMed ID: 8205475
[TBL] [Abstract][Full Text] [Related]
24. Adrenalectomy decreases vasoactive intestinal peptide mRNA levels in the rat suprachiasmatic nucleus.
Gozes I; Avidor R; Giladi E; Shani Y; McEwen BS; Dussaillant M; Rostene W
Neurosci Lett; 1994 Feb; 167(1-2):24-8. PubMed ID: 8177525
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in the daily rhythm of vasoactive intestinal polypeptide but not arginine vasopressin messenger ribonucleic acid in the suprachiasmatic nuclei.
Krajnak K; Kashon ML; Rosewell KL; Wise PM
Endocrinology; 1998 Oct; 139(10):4189-96. PubMed ID: 9751499
[TBL] [Abstract][Full Text] [Related]
26. Changes in vasoactive intestinal peptide mRNA levels in the rat suprachiasmatic nucleus following p-chlorophenylalanine (PCPA) treatment under light/dark conditions.
Kawakami F; Okamura H; Tamada Y; Nakajima T; Ibata Y
Neurosci Lett; 1995 Nov; 200(3):171-4. PubMed ID: 9064604
[TBL] [Abstract][Full Text] [Related]
27. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
Kalamatianos T; Kalló I; Piggins HD; Coen CW
J Comp Neurol; 2004 Jul; 475(1):19-35. PubMed ID: 15176082
[TBL] [Abstract][Full Text] [Related]
28. Photoperiodic exposure and time of day modulate the expression of arginine vasopressin mRNA and vasoactive intestinal peptide mRNA in the suprachiasmatic nuclei of Siberian hamsters.
Duncan MJ; Cheng X; Heller KS
Brain Res Mol Brain Res; 1995 Sep; 32(2):181-6. PubMed ID: 7500829
[TBL] [Abstract][Full Text] [Related]
29. Cellular levels of messenger ribonucleic acids encoding vasoactive intestinal Peptide and gastrin-releasing Peptide in neurons of the suprachiasmatic nucleus exhibit distinct 24-hour rhythms.
Zoeller RT; Broyles B; Earley J; Anderson ER; Alberst HE
J Neuroendocrinol; 1992 Feb; 4(1):119-24. PubMed ID: 21554586
[TBL] [Abstract][Full Text] [Related]
30. Interaction of colocalized neuropeptides: functional significance in the circadian timing system.
Albers HE; Liou SY; Stopa EG; Zoeller RT
J Neurosci; 1991 Mar; 11(3):846-51. PubMed ID: 2002363
[TBL] [Abstract][Full Text] [Related]
31. Diurnal oscillation in vasoactive intestinal peptide gene expression independent of environmental light entraining.
Glazer R; Gozes I
Brain Res; 1994 Apr; 644(1):164-7. PubMed ID: 8032943
[TBL] [Abstract][Full Text] [Related]
32. Loss of day-night differences in VIP mRNA levels in the suprachiasmatic nucleus of aged rats.
Kawakami F; Okamura H; Tamada Y; Maebayashi Y; Fukui K; Ibata Y
Neurosci Lett; 1997 Jan; 222(2):99-102. PubMed ID: 9111738
[TBL] [Abstract][Full Text] [Related]
33. Disrupted circadian rhythms in VIP- and PHI-deficient mice.
Colwell CS; Michel S; Itri J; Rodriguez W; Tam J; Lelievre V; Hu Z; Liu X; Waschek JA
Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R939-49. PubMed ID: 12855416
[TBL] [Abstract][Full Text] [Related]
34. [125I]Vasoactive intestinal peptide binding in rodent suprachiasmatic nucleus: developmental and circadian studies.
Robinson ML; Fuchs JL
Brain Res; 1993 Mar; 605(2):271-9. PubMed ID: 8481777
[TBL] [Abstract][Full Text] [Related]
35. Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats.
Gozes I; Shani Y
Endocrinology; 1986 Dec; 119(6):2497-501. PubMed ID: 3780537
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the optic pathway during development affects vasoactive intestinal peptide mRNA expression.
Holtzman RL; Malach R; Gozes I
New Biol; 1989 Nov; 1(2):215-21. PubMed ID: 2488706
[TBL] [Abstract][Full Text] [Related]
37. Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue.
Schulte-Bockholt A; Meier DA; Hopp K; Stadelmann A; Otterson MF; Telford GL; Koch TR
Neurosci Lett; 1993 Dec; 164(1-2):101-4. PubMed ID: 8152582
[TBL] [Abstract][Full Text] [Related]
38. Timed hypocaloric food restriction alters the synthesis and expression of vasopressin and vasoactive intestinal peptide in the suprachiasmatic nucleus.
Andrade JP; Pereira PA; Silva SM; Sá SI; Lukoyanov NV
Brain Res; 2004 Oct; 1022(1-2):226-33. PubMed ID: 15353233
[TBL] [Abstract][Full Text] [Related]
39. Circadian change of VIP mRNA in the rat suprachiasmatic nucleus following p-chlorophenylalanine (PCPA) treatment in constant darkness.
Okamura H; Kawakami F; Tamada Y; Geffard M; Nishiwaki T; Ibata Y; Inouye ST
Brain Res Mol Brain Res; 1995 Apr; 29(2):358-64. PubMed ID: 7609623
[TBL] [Abstract][Full Text] [Related]
40. Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei.
Cagampang FR; Sheward WJ; Harmar AJ; Piggins HD; Coen CW
Brain Res Mol Brain Res; 1998 Feb; 54(1):108-12. PubMed ID: 9526060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
